Utak Laboratories Inc FDA Record
- No warning letters matched by name
Utak Laboratories Inc has 1 FDA recall, 0 inspections, 23 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Utak Laboratories Inc" is on file.
- Latest recall
- Z-2407-2020 · Class III · Mar 20, 2020
- Latest 510(k)
- Apr 12, 1991
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 1 | Nov 11, 2026 (checked Nov 15, 2026, unchanged) | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 23 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 0 | Nov 17, 2026 | Newest record Nov 9, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
Reviewing Utak Laboratories Inc as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Utak Laboratories Inc yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| Z-2407-2020 | Class III | Utak NR Trace Elements Serum Control, 5 ml, REF 66816. The responsible firm on the label is UTAK… | Mar 20, 2020 |
Recent 510(k) clearances
| K-Number | Device | Date |
|---|---|---|
| K903061 | UTAK LABORATORIES TOXICOLOGY CONTROL | Apr 12, 1991 |
| K883147 | TRACE ELEMENTS SERUM TOXICOLOGY CONTROL | Oct 6, 1988 |
| K862418 | BENZODIAZEPINES TOXICOLOGY CONTROL | Nov 13, 1986 |
| K862419 | SERUM VANCOMYCIN TOXICOLOGY CONTROL | Nov 13, 1986 |
| K862421 | SERUM CLONAZEPAM TOXICOLOGY CONTROL | Nov 5, 1986 |
| K862420 | UTAK-STABBS TOXICOLOGY CONTROL | Aug 4, 1986 |
| K831736 | TRICYCLIC ANTIDEPRESSANTS | Jul 28, 1983 |
| K831735 | MAPROTILINE | Jul 26, 1983 |
| K831741 | FLURAZEPAM TOXICOLOGY CONTROL | Jul 26, 1983 |
| K831738 | CAFFINE TOXICOLOGY CONTROL | Jul 26, 1983 |
| K831734 | AMOXAPINE 8-HYDRO-XYAMOXAPINE | Jul 26, 1983 |
| K831737 | TRICYCLIC ANTIDEPRESSNATS VI | Jul 19, 1983 |
| K831740 | DISOPYRAMIDE N-DESALKYLDISOPYRAMIDE | Jul 6, 1983 |
| K831739 | PENTOBARBITAL TOXICOLOGY CONTROL | Jul 6, 1983 |
| K810201 | TOXICOLOGY CONTROL | Feb 4, 1981 |
| K800888 | TRICYCLIC ANTIDEPRESSANTS I TX CONTROL | May 2, 1980 |
| K800887 | HYPNOTICS PLUS SALICYLATE TX CONTROL | Apr 29, 1980 |
| K800889 | TRICYCLIC ANTIDEPRESSANT II TX CONTROL | Apr 29, 1980 |
| K800885 | BARBITURATES TOXICOLOGY CONTROL | Apr 29, 1980 |
| K800883 | CARDIACS I TOXICOLOGY CONTROL | Apr 29, 1980 |
Utak Laboratories Inc and the FDA: common questions
Has Utak Laboratories Inc received an FDA warning letter?
No FDA warning letter addressed to the name "Utak Laboratories Inc" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has Utak Laboratories Inc received an FDA Form 483?
FDA has not published a Form 483 for "Utak Laboratories Inc" in its reading room. FDA publishes some Form 483s, not all of them.
Has Utak Laboratories Inc had an FDA recall?
Yes. Utak Laboratories Inc has 1 FDA recall on record. The most recent started Mar 20, 2020.
Need more than this page shows? Ask about Utak Laboratories Inc in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.